About six to nine percent of women will develop diabetes during pregnancy. We spoke with Gretchen Koontz, M.D., M.S., a perinatologist at Maternal-Fetal Specialists in Georgia, to learn more about gestational diabetes (GDM) and understand the ins and outs of this condition.
Simply put, gestational diabetes is diabetes diagnosed in pregnancy and is tested for around 24 to 28 weeks’ gestation. GDM risk factors include advanced maternal age, increased maternal Body Mass Index (BMI), high blood pressure, a family history of diabetes, diabetes in a previous pregnancy and pregnancy with multiples. For women without these risk factors, GDM can be linked to the placenta as it releases a hormone that, in some women, will cause the body to reject its own insulin.
Poorly controlled GDM in pregnancy can result in complications at birth such as macrosomia, birth trauma, neonatal morbidities such as hypoglycemia, preterm birth, and even stillbirth. Women with GDM are at increased risk of developing polyhydramnios and preeclampsia, which can lead to preterm birth.
In the United States, GDM is most commonly diagnosed through a one-hour glucose screening, known as the glucola. Women drink a syrupy glucose solution and subsequently have their blood drawn. If glucose levels are elevated, the pregnant patient completes a three-hour follow-up test for confirmation.
If GDM is confirmed, patients are then advised to check their blood glucose levels at least four times per day and send their results back to their physician weekly for evaluation. Fetal growth evaluations are recommended monthly, and for those women requiring insulin or an oral hypoglycemic agent, antenatal testing is started at 32 weeks.
For many patients, remembering to monitor glucose levels may be difficult. In addition, many people fear needle sticks and blood draws. Given these obstacles, Dr. Koontz is hopeful that the newer glucose sensors and monitors used in the pediatric and general diabetes population will soon enter the market for safe use in pregnancy.
To learn more about the full scope of services Obstetrix Medical Group offers, including gestational diabetes management, visit mednax.com/Obstetrix.
Dr. Koontz attended medical school at Emory University. She then completed her residency in Obstetrics and Gynecology at the University of Washington and her fellowship in Maternal-Fetal Medicine at Wake Forest University. Dr. Koontz has over 20 years of experience and is board certified in OB/GYN and Maternal-Fetal Medicine.